A Phase 1, Randomized, Double-Blind Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, Food Effects, and QT/QTc Interval Impact of VB19055 Tablets in Healthy Chinese Adult Subjects
Latest Information Update: 05 Dec 2025
At a glance
- Drugs VB 19055 (Primary)
- Indications Hypertension
- Focus Adverse reactions
Most Recent Events
- 05 Dec 2025 New trial record